Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Hsi

Showing results (161-170 of 330) with videos related to

Pageof 33
Sort By:
BMC Cancer|July 29, 2010
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patientsAnjali S Advani, Sarah E Gibson, Elizabeth Douglas, et al.
Leukemia & Lymphoma|October 1, 2015
Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphomaKelli M Clark Schneider, Peter M Banks, Angela M B Collie, et al.
Human Pathology|September 1, 2009
Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomasRodney R Miles, Cohra C Mankey, Charlie E Seiler, et al.
British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Leukemia & Lymphoma|November 21, 2008
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science studyEric D Hsi, Sin-Ho Jung, Raymond Lai, et al.
Virchows Archiv : an International Journal of Pathology|October 12, 2023
Correction to: Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySocorro Maria Rodriguez-Pinilla, Stefan Dojcinov, Snjezana Dotlic, et al.
Virchows Archiv : an International Journal of Pathology|August 2, 2023
Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySocorro Maria Rodriguez-Pinilla, Stefan Dojcinov, Snjezana Dotlic, et al.
Virchows Archiv : an International Journal of Pathology|August 10, 2023
Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySnjezana Dotlic, Sarah E Gibson, Sylvia Hartmann, et al.
The American Journal of Surgical Pathology|October 1, 2019
Practical Approaches on CD30 Detection and Reporting in Lymphoma DiagnosisMina L Xu, Ali Gabali, Eric D Hsi, et al.
The American Journal of Surgical Pathology|January 2, 2007
Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphomaScott J Rodig, Kerry J Savage, Ann S LaCasce, et al.
Pageof 33

Showing results (161-170 of 330) with videos related to

Sort By:
Pageof 33
BMC Cancer|July 29, 2010
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patientsAnjali S Advani, Sarah E Gibson, Elizabeth Douglas, et al.
Leukemia & Lymphoma|October 1, 2015
Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphomaKelli M Clark Schneider, Peter M Banks, Angela M B Collie, et al.
Human Pathology|September 1, 2009
Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomasRodney R Miles, Cohra C Mankey, Charlie E Seiler, et al.
British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Leukemia & Lymphoma|November 21, 2008
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science studyEric D Hsi, Sin-Ho Jung, Raymond Lai, et al.
Virchows Archiv : an International Journal of Pathology|October 12, 2023
Correction to: Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySocorro Maria Rodriguez-Pinilla, Stefan Dojcinov, Snjezana Dotlic, et al.
Virchows Archiv : an International Journal of Pathology|August 2, 2023
Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySocorro Maria Rodriguez-Pinilla, Stefan Dojcinov, Snjezana Dotlic, et al.
Virchows Archiv : an International Journal of Pathology|August 10, 2023
Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySnjezana Dotlic, Sarah E Gibson, Sylvia Hartmann, et al.
The American Journal of Surgical Pathology|October 1, 2019
Practical Approaches on CD30 Detection and Reporting in Lymphoma DiagnosisMina L Xu, Ali Gabali, Eric D Hsi, et al.
The American Journal of Surgical Pathology|January 2, 2007
Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphomaScott J Rodig, Kerry J Savage, Ann S LaCasce, et al.
Pageof 33